Just when it felt like the market would never go down again we’ve got some weakness this morning. While I’d love to go buck wild on the short side, I suspect this week should have relatively low volume… and you know what they say about shorting dull markets. So I’ll be focusing exclusively on very high-volume movers this week — long or short.
On Today’s Calendar:
- 10:00 — Leading Indicators
More Calendars: U.S. Earnings | Conf. Calls | Surprises | IPO | Economic
Potential swing trades:
See one of the recent ‘Chart Reading‘ posts for some potential swing candidates.
Potential day trades:
(From Briefing.com)
Gapping Down
PACT -22% (reports Q3), EHTH -7.5% (CIBC initiates at Underperform, $17 tgt), OTIV -6.4% (reports Q3 results), TM -3.6%, LMRA -3% (announces stock offering), UMBF -2.8%, HANS -2.8% (receives possible delisting notice from Nasdaq), FCX -2.1% (to acquire PD), Under $3: PLM -18%.
Gapping Up
PD +30% (to be acquired by FCX; up in sympathy: CUP +11%, PCU +6.3%), CTRX +19% (to be acquired by Actelion), MNT +12% (FDA approves sales of silicone breast implants), PCYC +12% (announces clinical data on Xcytrin), CYBX +10% (audit committee concludes stock option review), UBET +9% (favorable arbitration results with TVG), OS +7.5% (to be acquired by Russian steelmaker), EOP +7.3% (to be acquired), ASCA +7% (CEO unexpectedly dies, announces mgmt succession), ACOR +6.5% (extends Friday’s 10% move), SOMX +6.3% (insomnia drug shows positive results), CCE +6.3% (mentioned positively in Barron’s), SVI +6.3% (plans to list on Nasdaq), AGN +6.1% (FDA approves sales of silicone breast implants), EFUT +5% (stock remains volatile), SONS +2.8% (Piper upgrade), SSL +2.5%, SCHW +1.9% (to sell its US Trust unit), MT +1.7%, DD +1.6% (mentioned positively in Barron’s), MRVL +1.6% (Cramer bullish on Mad Money), Under $3: TRPS +26% (to sell its informatics business).
Disclaimer & How I use this list
